GIMBHIBreakthrough in Depression Treatment: FDA Clears Revolutionary 5-Day Magnetic TherapyThe landscape of mental health treatment is experiencing a transformative shift with two major developments in Transcranial Magnetic…Nov 13Nov 13
GIMBHIGIMBHI ‘s Q&A with Cope Notes’s CEO and Founder, Johnny CrowderJohnny Crowder is a mental health advocate, public speaker, and entrepreneur. He is the founder and CEO of Cope Notes, a mental health…Aug 4Aug 4
GIMBHIArcade TherapeuticsWe’re excited to share to the broader GIMBHI community an opportunity to invest in an Influencer Round opened up by Arcade Therapeutics…Jul 31Jul 31
GIMBHI66% Increase in Antidepressant Usage: GIMBHI’s Q&A with Dr. Kao-Ping ChuaHow much has antidepressant dispensing increased recently?Jul 7Jul 7
GIMBHIGIMBHI ‘s Q&A with Talkspace’s Chief Growth Officer, Erin BoydErin Boyd is Talkspace’s (TALK) Chief Growth Officer. With a 25-year track record of managing sales operations, business development…Jun 20Jun 20
GIMBHIMental, Behavioral, & Brain Health Startups: Q2 2022 Market UpdateTHE HEALTHCARE TECHNOLOGY MARKETAug 13, 2022Aug 13, 2022
GIMBHICHALLENGES & OPPORTUNITIES IN THE MENTAL HEALTH CHATBOT SPACEData Input: One limitation of chatbots is access to certain types of data. When a chatbot interacts with you, the chatbot could plausibly…Aug 13, 2022Aug 13, 2022